JUL 2025 VOLUME 30 ISSUE 1 MBBS New and enriched opportunities for aspiring doctors and clinician-scientists Advancing the
Editorial Team Editor-in-Chief Ada Leung Wing-yee Managing Editors Brenda Yau Florence Chan Executive Editors Tina Chan Pauline Yung Feature Writer Kathy Griffin Graphic Design Good Morning Design www.med.hku.hk All rights reserved 2025 Care for the Environment 保護環境 If you would like to opt-out of receiving a printed copy and subscribe to the e-version of HKUMed News, please complete the online form by scanning the above QR code (for alumni), or send us an e-mail: mfedit@hku.hk. 如欲取消訂閲印刷紙本及轉為接收電子版HKUMed News，請掃描二維碼並填寫網上表格（供校友填寫）或電郵至 mfedit@hku.hk。 The information contained in this publication is solely for the purpose of reporting the Faculty’s latest developments. None of such information is intended to be for, nor shall therefore be treated as, dissemination of professional service information of doctors to the public. 本刊物的內容僅為報導學院最新發展，其所提供的內容並非，亦不應被視為向公眾傳播醫生的專業服務的資訊。
02 Figures: Global Rankings 2025 and The Faculty in 2024 世界大學排名2025及醫學院2024年回顧 04 Feature 專題故事 Advancing the MBBS – New and Enriched Opportunities for Aspiring Doctors and Clinician-Scientists 優化醫學士課程―成就未來仁醫與臨床科學家 17 An Evening of Gratitude: Endowed Professorship 明德教授席感謝宴 Global Outreach to Recruit Talent, Engage Alumni and Promote Collaboration 全球廣納賢才 滙聚校友 促進合作新機遇 HKUMed Drives Global Health Innovation: AI and Biotech 醫學院推動全球醫療健康：AI及生物科技 Symposium Advances Global Health Through Scientific Innovation 研討會推動科學創新 促進全球健康發展 ‘Grand Challenges in Medical Education – Training Doctors for the Fifth Industrial Revolution’ Symposium 第五次工業革命與醫學教育變革研討會 20 The 213th Congregation 第213屆學位頒授典禮 22 Feature+ 專題+ HKUMed Cure for Leukaemia Advances Globally 港大口服砒霜藥 全球抗癌新突破 28 Feature+ 專題+ Leading with Excellence: School of Nursing Celebrates 30 Years of Innovation and Leadership 護理學院30周年―卓越創新 引領未來 32 Faculty Prize Presentation Ceremony 學院頒獎典禮 Spring Reception 2025 乙巳蛇年新春團拜 Inaugural Lecture of the Leong Che-Hung Distinguished Visiting Professorship in Leadership 梁智鴻傑出訪問教授席（領航）首屆講座 Hong Kong InnoHealth Cup 2025 香港健康創科盃 2025 HKUMed Launches Pioneering Sports Health Initiative to Foster Community Wellness 新推「運動健康」計劃 促進社區健康 World Health Day: Stroke Prevention Promotion Event 世界健康日: 預防中風宣傳活動 Standard Chartered Hong Kong Marathon 2025 渣打香港馬拉松 2025 Staff-Student Sports & Wellness Gala 2025 師生運動與健康嘉年華 2025 36 People First @HKUMed – Sports and Family Fun Day 以人為本―運動與家庭同樂日 37 Achievements 獎項與成就 47 Activities and Events 活動紀要 53 People 人物 Hello 新臉孔 Appointments and Promotions 任命與晉升 Alumni News and Reunions校友活動及聚會 Student Activities 學生活動 Student Achievements 學生成就 In Remembrance 永遠懷念 70 Donations 捐贈者名單 1 HKUMed News Summer 2025
^ incl. MBBS and MBBS(DMS) # incl. BNurs(FT) and BNurs(ALT) Professoriate Staff 教授級人員 325 Postgraduate Students 研究生 2,181 Honorary Academic Staff 名譽學術人員 3,233 Undergraduate Students 本科生 3,520 Undergraduate Programmes (Full-time) and Student Numbers本科生課程（全日制）及學生人數 Bachelor of Medicine and Bachelor of Surgery^ Bachelor of Nursing# Bachelor of Chinese Medicine Bachelor of Pharmacy Bachelor of Biomedical Sciences Bachelor of Science in Bioinformatics Bachelor of Arts and Sciences in Global Health and Development Year 1 331 263 27 45 50 27 24 Year 2 306 200 27 33 46 11 25 Year 3 249 228 24 39 66 11 23 Year 4 309 222 23 38 53 - 29 Year 5 280 234 21 - - - - Year 6 235 - 21 - - - - Total 1710 1147 143 155 215 49 101 The Faculty in 2024 醫學院2024年回顧 (as of December 2024) FIGURES QS World University Rankings By Subject 2025: Medicine 2025年QS世界大學「醫學」學科排名 in Asia 亞洲 in Asia 亞洲 in the World 全球 in the World 全球 Times Higher Education World University Rankings By Subject 2025: Medical and Health 2025年《泰晤士高等教育》世界大學「醫學與健康」學科排名 2nd 3rd 24th 21st GLOBAL RANKINGS世界大學排名 2025 2
RGC General Research Fund/ Early Career Scheme RGC Areas of Excellence/ Theme-based Research Scheme/ Strategic Topics Grant 51 4 projects HK$70.4M projects HK$164.9M (3 projects as PI and 1 project as Co-I) Public lectures/ symposia/ forums 公開講座/ 座談會/ 論壇 Regular newspaper columns 報章定期專欄 Media interviews and press conferences 媒體訪問及新聞發布會 Media coverage generated 傳媒報道總計 Health programmes on television and radio 電視及電台醫療健康節目 364 444 415 4,641 892 Research Grants 研究資助 Research Output 研究成果 • The Faculty’s refereed research output saw 1,818.8 items produced in 2023/2024, accounting for 32.4% of the University’s total of 5,611.7 refereed items. • In 2023 and 2024, 116 important publications of impact factors over 40 were published in The Lancet, New England Journal of Medicine, British Medical Journal, Nature Reviews Disease Primers, Nature Reviews Microbiology, Journal of the American Medical Association, World Psychiatry, Nature Medicine, Annals of Oncology, Nature, Cancer Cell, Lancet Neurology, Nature Reviews Gastroenterology & Hepatology, Cell, Science, Journal of Clinical Oncology, Nature Reviews Cardiology, Lancet Oncology, Signal Transduction and Targeted Therapy. • According to Clarivate Analytics, our researchers have published 602 Highly Cited Papers, and 32 staff members are listed as Highly Cited Researchers. As of July 2024, among 196 HKU staff on the list of top 1% scholar, 70 of them are from HKUMed, making up 35.7% of the top 1% scholar in HKU. Public Education 公眾教育 Postgraduate Education 研究生課程 • The Faculty offered 12 taught postgraduate programmes in 2024/25. • The Faculty admitted 325 Research Postgraduate (RPg) students in 2024/25. A total of 17 of new PhD students have been awarded Hong Kong PhD Fellowships by the Research Grants Council (RGC) and 17 have been awarded the HKU Presidential PhD Scholarship. HK$471.3M in total RGC Research Impact Fund/ Collaborative Research Fund Health and Medical Research Fund Commissioned Grant Others Health and Medical Research Fund (Provisional) Innovation and Technology Fund 3 1 53 63 34 projects HK$17.9M project HK$8.0M projects HK$69.4M projects HK$$66.7M projects HK$$74.0M Awarded to Faculty members 3 HKUMed News Summer 2025
FEATURE Good doctoring requires more than knowledge. It also requires compassion and curiosity – qualities that can be cultivated with opportunities to explore and flourish. HKUMed has been developing initiatives that do just that, thereby enhancing the calibre of our graduates and giving them an edge in a competitive marketplace. Advancing the MBBS New and Enriched Opportunities for Aspiring Doctors and Clinician-Scientists
The Enrichment Year, which had its first cohort in 2018/19, provides all Bachelor of Medicine and Bachelor of Surgery (MBBS) students with a full year of life-enhancing experiences that make them more independent, more mature and ready to take charge. Meanwhile, the new four-year MBBS (Graduate Entry) track, to be launched in September, offers a pathway into medicine for degree-holders with a strong passion and aspiration to become doctors. It offers the same professional core components and assessment requirements as the accredited six-year MBBS programme, and an opportunity to diversify our student body to better serve Hong Kong’s varied patient population. Students of the new track can also opt to delve deeper into medical discovery through the Master of Research in Medicine (MRes[Med]), to work with world-class researchers and position themselves to become future clinician-scientists. Professor Chak-sing Lau, Vice-President & Pro-Vice-Chancellor (Health) and Dean of Medicine, has been a driving force behind these initiatives and believes that patients will ultimately benefit. ‘Medicine is advancing rapidly and so are Hong Kong’s needs for medical professionals. HKUMed keeps our programmes under constant review to ensure we can meet those needs. A key aim for us is to give our students opportunities for personal and professional development, alongside the rigorous education we provide. ‘The maturity and broader perspectives they acquire will benefit patients, research, medicine as a whole, and the students themselves,’ he said. ‘We are striving to address that need by providing talent who are highly competent and compassionate and by meeting the aspirations of young people to pursue meaningful careers in medicine.’ Professor Chak-sing Lau 5 HKUMed News Summer 2025
‘We have had great feedback from students – many feel it was their best year at HKUMed.’ Professor Kendrick Shih Co The Enrichment Year (EY) is a rare chance for students to immerse themselves in their interests, gain knowledge, and grow both personally and professionally, before the demands of clinical training set in. Currently, all medical students spend their third year pursuing activities in one or more of three areas: service/ humanitarian work, research attachment, and intercalation (earning a second degree or credits from free electives in a different field). To date, over 1,500 students have participated in the EY, with nearly 600 earning a second degree (including 59 with an MRes[Med]), while successfully completing over 270 service/ humanitarian projects and 470 research attachment projects across more than 45 countries and regions. The variety of their experiences has ranged from publishing research in The Lancet, earning an MSc from the London School of Hygiene and Tropical Medicine and earning a certificate in cinematography from the New York Film Academy, to doing service work with Ukrainian war refugees in Poland, to give a small sample. Professor Kendrick Shih Co, Assistant Dean (Student Wellness & Engagement), who oversees the EY programme, said the experience gives students advantages in securing top jobs. ‘We are seeing our students want to make the best use of the year and equip themselves with skills and qualifications that go beyond what they can get in a medical degree programme,’ said Professor Shih. ‘In the Master’s degrees, for instance, they often interact with people who are more mature and experienced. This is a great learning experience for our students, who also gain skills that will be helpful in their careers.’ The Faculty offers guidance and support to help all students make the best of the year. New partners and modalities are also being added to keep pace with modern life, such as the University of Leeds in the United Kingdom which will offer a number of master’s degree programmes to our MBBS students in EY2026/27, and the Hong Kong Science & Technology Parks where students will have the opportunity to work with several different companies to understand the nature of startups and innovation. ‘We have had great feedback from students – many feel it was their best year at HKUMed. New students are getting excited, too, and a lot of them are asking us how they can plan for the EY from their first year,’ Professor Shih added. Eye-opening Enrichment FEATURE 6
‘These postgraduate students appear mature, determined and focused. Hopefully they will grasp the basic science and clinical aspects more quickly and cope well with the demands of the MBBS.’ Professor Gordon Wong Tin-chun Maturity and diversity are also valued through the MBBS (Graduate Entry) track, which builds on the success of the Second Chance path launched a few years ago to admit students with a first degree in another discipline and allow them to complete studies in five years instead of six. ‘These postgraduate students appear mature, determined and focused. Hopefully they will grasp the basic science and clinical aspects more quickly and cope well with the demands of the MBBS,’ said Professor Gordon Wong Tin-chun, the newly appointed Associate Dean (Clinical Sciences Education), who is overseeing overall academic development. Professor Wong, along with Professor Siddharth Sridhar from the Department of Microbiology, School of Clinical Medicine, will jointly look after the programme. The new track is four years instead of five and is designed with reference to similar programmes at other leading medical schools around the world, such as Cambridge and Oxford universities and medical schools in North America. It was approved by the University Grants Committee to commence this September and the programme update has been submitted to the Medical Council of Hong Kong. The initial intake of 25 students will do intensive pre-clinical training in their first year, then clinical training alongside peers in the six-year MBBS for the remaining three years. After the first year, those with an interest in research can also engage in cuttingedge research projects with world-class professors through the one-year MRes[Med], thereby completing two degrees in five years. ‘We have a strong network of teaching hospitals and comprehensive hardware and software support for all medical students. We will give them clinical training in both public and private hospitals in Hong Kong and other cities in the Greater Bay Area,’ Professor Wong explained. Second Chances through Graduate Entry 7 HKUMed News Summer 2025
Master of Research in Medicine: A pathway for aspiring clinician-scientists The MRes[Med] is a stepping stone for all medical students to undertake original research and learn from top scholars. More than 100 HKUMed academics are in the top 2% of their fields worldwide, and 32 were named to the prestigious Highly Cited Researchers 2024 list by Clarivate Analytics. MRes[Med] students in the six-year MBBS programme typically do their data collection and other groundwork in the Enrichment Year, while those in Graduate Entry will start their research after their first year. All students have until graduation to write up their results and they will be awarded the MRes[Med] after completing the MBBS. Students also get exceptional exposure to the academic world. From 2018/19-2023/24, MBBS students gave 140 presentations at conferences, published 118 research papers, and received 29 prizes and 13 grants/ scholarships. ‘It’s very important for the growth of our Faculty that we can train up clinician-scientists who can understand research needs from the perspectives of both the bedside and the laboratory bench,’ Professor Lau said. FEATURE Our Dynamic Curriculum HKUMed has long been at the frontier of medical training in Hong Kong and Asia, which we are continuing to enhance with new technologies, including artificial intelligence, and other measures to prepare students for the future workplace. The EY and Graduate Entry track underscore our commitment to provide an innovative, dynamic curriculum that produces well-rounded medical professionals for both patient care and research. ‘As Hong Kong faces the challenges of an ageing population and a shortage of medical manpower, accelerating the training of talents has become an urgent task,’ Dean Lau said. ‘We are striving to address that need by providing talent who are highly competent and compassionate and by meeting the aspirations of young people to pursue a meaningful career in medicine.’ 8
Enrichment Year International Exposure (up to 2024/25 academic year) 增潤學年海外體驗（至2024/25學年完結） Students’ Enrolment in Master of Research in Medicine (MRes[Med]) during Enrichment Year 學生修讀醫學研究碩士 (Figures since the first cohort of Enrichment Year in 2018/19 由第一年增潤學年開始) Second degree earned (including intercalated & master’s degree) 獲得第二學位（包括增插課程學位及碩士學位） Number of grants and scholarships 獲頒助學金及 獎學金數目 Number of prizes awarded 獲獎數目 Number of publications 研究成果發表數目 Graduates awarded MRes[Med] upon MBBS graduation MBBS畢業生同時 獲授MRes[Med] Number of conferences attended (as a presenter) 參與會議 （以發表人身份） Research attachments completed 完成研究實習 Service/ humanitarian work projects completed 完成服務/ 人道救援工作 Countries/ regions across 5 continents for intercalation, research attachment and/ or service/ humanitarian work 增插課程、研究實習和服務/ 人道救援工作遍佈五大洲的 國家/ 地區 Local and Overseas Partners 本地及海外夥伴機構 Students went overseas 學生前赴海外 600+ 13 29 118 59 140 470+ 960+ 270+ 45+ 60+ 9 HKUMed News Summer 2025
優化醫學士課程 成就未來仁醫與臨床科學家 優秀的醫生不僅需要專業知識，還必須具備同理心與求知的熱忱。醫學院近年推出多元 創新舉措，不僅提升了畢業生的整體質素，更使他們在競爭激烈的醫療領域中脫穎而出。 具代表性的計劃之一是於2018/19學年啟動的「增潤學年」，為所有內外全科醫學士課程（MBBS） 學生提供一整年的充實體驗，從而培養他們的獨立性、成熟度和責任感。 與此同時，學院將於今年9月新增四年制MBBS第二學位入學途徑，專為持有學位且有志行醫者 設計。該課程核心與六年制MBBS一致，新途徑有助吸纳不同背景的學生，以更全面地服務香港 的病患群體。學生更可選修醫學研究碩士（MRes[Med]）課程，跟隨頂尖學者開展研究。 副校長（健康）兼醫學院院長劉澤星教授是這些計劃的推動者。他說：「香港醫療需求日新月異， 我們必須持續優化課程，兼顧學生的專業訓練與個人發展，培育切合社會所需的醫護人才。學生 更趨成熟、具備更廣闊的視野，就能令患者、醫學研究、整體醫療環境，以至他們自身受益。」 FEATURE
「學生的反饋都非常 正面――許多更 認為增潤學年是 他們在港大醫學院 最佳的一年。」 ――施愷廸教授 「這些學生看起來 成熟、堅定且專注。 希望他們能迅速掌握 基礎科學和臨床 知識，並順利應對 醫學課程的要求。」 ――黃田鎮教授 第二學位入學途徑： 為有志者開啟醫途 四年制MBBS第二學位入學途徑同樣重視學生的成熟度與多 樣性，學院過往亦曾取錄第二學位學生入讀MBBS，讓他們 以五年（而非六年）完成課程。 新任副院長（本科教育- 臨床科學）黃田鎮教授闡釋：「這些學 生看起來成熟、堅定且專注。希望他們能迅速掌握基礎科學 和臨床知識，並順利應對醫學課程的要求。」黃教授負責統籌 醫學院整體學術教育發展，他和臨床醫學學院微生物學系 的薛達教授共同統籌新設的第二學位入學途徑課程。 四年制醫科第二學位課程架構參考全球頂尖醫學院，如劍橋大 學、牛津大學及北美醫學院的類似計劃而設計，已獲大學教 育資助委員會批准，將於今年9月入學，課程資料亦已提交香 港醫務委員會。 首屆25名學生將在第一年接受密集的臨床前培訓，隨後三年 與六年制MBBS學生一同進行臨床訓練。對研究有興趣的學 生，可在第一年後透過修讀一年的MRes[Med]參與尖端研究 項目，從而五年內取得兩個學位。 黃教授補充道：「我們擁有強大的教學醫院網絡和完善的軟硬 件配套，學生將獲安排在本港及大灣區其他城市的公私營醫院 接受臨床培訓。」 增潤學年：拓濶視野 增潤學年為學生提供了一個難得的機會，讓他們在進入臨床 培訓前，全心投入自身興趣，拓展知識，並在個人與專業層 面上成長。目前，所有醫科生在第三年可選擇透過服務/ 人 道救援工作、研究實習和增插課程（攻讀第二學位或選修其他 領域課程獲取學分），深入探索志趣。迄今已有逾1,500名學 生參與，其中約600人獲得第二學位（包括59個MRes[Med] 學位）。此外，學生共完成逾270項服務/ 人道救援工作及 470項研究實習，足跡遍佈全球超過45個國家與地區。 他們的經歷豐富多彩，過往例子包括：於《刺針》發表研究論 文、取得倫敦衞生與熱帶醫學院的理學碩士學位、獲得紐約 電影學院的電影攝影證書，或在波蘭援助烏克蘭難民等。 負責統籌增潤學年計劃的助理院長（學生福祉及拓展）施愷廸 教授分享：「學生希望充分利用這一年，獲取超越醫學學位課 程的技能與資格，例如在攻讀碩士學位時，他們常與更成熟 且經驗豐富的人士交流，這對學生而言是極佳的學習機會， 同時也為未來的職業生涯累積寶貴技能。」 學院亦協助學生充分利用這一年，同時持續新增合作夥伴與 模式，例如英國里茲大學將於2026/27的增潤學年為MBBS 學生提供多個碩士學位課程，學生更有機會在香港科學園的 初創公司學習，深入了解創業與創新。 施教授補充：「學生的反饋都非常正面――許多更認為這是他 們在醫學院最佳的一年；甚至新生也從一年級就開始規劃增 潤學年。」 「我們致力培育兼具 卓越能力與人文關懷 的醫者，同時滿足 年輕人投身有意義 醫學專業的期望。」 ――劉澤星教授 11 HKUMed News Summer 2025
醫學研究碩士： 臨床科學家的搖籃 MRes[Med]是醫科生開展原創研究並向頂尖學者學習的重要 基石。醫學院有過百位學者為全球首2%頂尖科學家，更有 32名學者膺選科睿唯安「2024年度最廣獲徵引研究人員」。 六年制MBBS的學生通常在增潤學年進行數據收集等基礎工 作，而循新途徑入學的學生則在完成第一年課程後開始研究。 所有學生可在畢業前完成論文，並在取得MBBS後獲頒 MRes[Med]。 學生在學術領域上亦獲得豐富的學習機會。2018/19至 2023/24年間，MBBS學生在學術會議上發表了140篇報告， 出版118篇研究論文，並獲得29個獎項與13項研究資助/ 獎 學金。 劉澤星教授強調：「能培育兼具臨床與研究視野的人才，全面 理解研究需求，是醫學院發展的關鍵。」 FEATURE 課程設計 與時俱進 港大醫學院已持續透過人工智能等新科技與其他措施優化課 程。劉教授總結：「面對人口老化與醫護短缺，我們必須加快 培育兼具卓越能力與人文關懷的醫者，同時滿足年輕人投身 有意義醫學專業的期望。」 12
Shaping a Future Clinician-Scientist 邁向臨床科學家之路 Year 3 MBBS student Henry began with a Biomedical Sciences degree at the Faculty, which gave him a solid grasp of anatomy, physiology, and pathology and a unique advantage when admitted to the MBBS programme. During his Enrichment Year, he went to the University of Cambridge where he immersed himself in an MPhil programme focused on infection biology and molecular immunology. He deepened his passion for immunology, which he had developed during his first degree. He also gained hands-on experience in translating scientific knowledge into real-world solutions. ‘The MPhil pushed me to ask deeper questions ― a mindset I now use daily in my medical studies,’ he reflected. Studying abroad also built resilience, preparing him for the rigours of clinical training. ‘More, I can meet peers from diverse backgrounds, all united by their passion for their fields,’ he said. 三年級醫科生陳熙的醫學之旅始於完成了醫學院生物醫學科學學士 學位，這段學習讓他扎實掌握解剖學、生理學和病理學知識，並 在入讀MBBS課程時具備獨特優勢。在增潤學年，他前赴劍橋大 學修讀以感染生物學與分子免疫學為核心的哲學碩士課程，深化 了在本科時期培養的免疫學熱忱，更累積了將科學知識轉化為實 務解決方案的經驗。他回憶道：「碩士學位促使我提出更深層的問 題， 這種思維模式如今已成為我醫學學習的日常。」留學經歷也磨 煉了他的韌性，為臨床訓練的嚴格要求做好準備。「此外，我能結 識來自多元背景的同儕，彼此都對專業領域懷抱熱情。」 Henry Chan Hei 陳熙 Student and Alumni Reflections 學生校友分享 Our students and alumni do more than just reach milestones; they embark on meaningful journeys. Read firsthand accounts below about the transformative experiences during Enrichment Year, the pursuit of research and innovation, and the unique paths taken by students and alumni who entered medicine after receiving a previous degree. Their stories reflect the curiosity, resilience and passion that drive our MBBS community forward. 成就背後都有獨一無二的成長旅程。在此，學生與校友將親述他們的 蛻變故事――由增潤學年的啟發、研究路上的突破，到從其他學位轉 修醫學的歷程。這些故事，正是MBBS一衆醫科生那份熱忱、韌性與 求知精神的真實寫照。 Scan QR code for all full interviews 請掃描二維碼閲讀所有訪問内容 13 HKUMed News Summer 2025
Pioneering Medical Research at Harvard 哈佛醫研探索之旅 During her Enrichment Year, Ananya Jain embarked on a transformative journey at Harvard University, immersing herself in cutting-edge research at the Center for Engineered Therapeutics (the CET Lab). She focused on glucocorticoidinduced osteocyte dysfunction using advanced techniques like western blotting and flow cytometry. ‘The CET Lab at Harvard Medical School offered a unique blend of engineering, biology, and clinical medicine,’ said Ananya, ‘which was perfectly aligned with my fascination for advancing medical treatments.’ The time at Harvard was a pivotal period, in which she gained invaluable technical skills beyond the clinical aspects of the MBBS curriculum. ‘Working at the CET Lab deepened my appreciation for the meticulous science behind medical breakthroughs and reinforced my commitment to bridging research and patient care,’ she said. Ananya 於增潤學年期間在哈佛大學工程治療研究實驗中心（簡稱 CET Lab）實習，專注於研究糖皮質激素引起的骨細胞功能障礙治 療技術（如蛋白質轉漬法和流式細胞技術）。她分享道：「哈佛醫學 院的 CET Lab結合工程、生物學和臨床醫學的獨特環境，與我對 醫學治療技術發展的興趣完美契合。」 她認為增潤學年令她獲得了 MBBS 課程臨床以外的技能。她總結道：「在CET Lab的工作加深 了我對醫學技術突破背後精密科學的理解，並加強了我利用研究去 改善照顧患者的決心。」 As a film enthusiast, Isabella spent her Enrichment Year at the New York Film Academy, studying cinematography. Over the course of the year, Isabella earned a diploma in cinematography, mastering lighting, rigging, equipment, and camera operation. She worked on diverse projects ― from advertisements and music videos to short films ― honing her craft through hands-on experience. One of her most unforgettable moments was braving the winter cold, waking at 1 am to drive to a beach in New Jersey to film a sunrise scene. ‘The freezing wind made it hard to even keep my eyes open,’ she recalled, ‘but seeing the final product made all the challenges worth it.’ Throughout the year, she not only gained valuable skills, but also had the opportunity to collaborate with industry professionals. Isabella also learnt the value of time management, meticulous preparation and teamwork, which directly benefitted her medical studies and future career. 身為電影愛好者的姚君盈在增潤學年前往紐約電影學院攻讀電影攝 影。在為期一年的進修中，她取得電影攝影文憑，熟練掌握燈光、 器械架設、設備操作與攝影機運鏡等。從廣告、音樂視頻到短片， 她透過實戰參與多元項目，不斷精進技藝。最難忘的經歷，是某個 寒冬凌晨一點，她驅車前往新澤西海灘拍攝日出場景。「刺骨寒風讓 人連睜眼都困難。」她回憶道。「但看到成品的瞬間，一切挑戰都值 得了。」這一年裡，她不僅累積寶貴技能，更與業界專業人士合作， 拓展視野。她亦深刻體會到時間管理、周密準備與團隊合作的價值， 這對她的醫學學習與未來職業生涯大有裨益。 Lights, Camera, Stethoscope 光影、鏡頭、聽診器 FEATURE Ananya Jain Isabella Iu Kwan-ying 姚君盈 14
Experience in Vanuatu Accelerates Growth 瓦努阿圖經歷加速成長 After enrolling in HKUMed’s Bachelor of Biomedical Sciences in 2016, Dr Ryan Lee secured one of only two articulation spots in the MBBS programme in 2018 ― graduating with both degrees in eight years. His unique trajectory allowed him to alternate between biomedical sciences and clinical training, deepening his understanding of medicine from multiple perspectives. ‘My biomedical background gave me a head start in the MBBS programme,’ said Dr Lee, ‘I could connect lab research to patient care, which made complex concepts click faster.’ He credits his dual training for fostering a holistic approach to medicine. His international experience―from clinical research at the University of British Columbia to attending ophthalmology lectures at Yale and Cambridge―further shaped his passion for patient health, leading to his new role as Medical Officer in Ophthalmology at Prince of Wales Hospital in July this year. 李宇軒醫生於2016年入讀醫學院生物醫學學士課程，後於2018 年獲得醫學院僅有的兩個銜接資格之一，升讀MBBS課程，在八 年內完成兩個學位。這獨特的軌跡讓他在生物醫學和臨床培訓之間 交互學習，從多角度深化對醫學的理解。他說：「我的生物醫學背 景為我的MBBS學習打下良好基礎。我能將實驗室研究與病患照 護聯繫起來，更容易理解複雜的概念。」他認為雙重訓練培養了他 對醫學的宏觀思維。從參與英屬哥倫比亞大學的臨床研究，到前 往耶魯大學和劍橋大學上眼科課程，他的國際經驗進一步激發了對 病患健康的熱情。今年七月，他踏上新崗位，成為威爾斯親王醫 院的眼科醫生。 Ken spent his Enrichment Year volunteering with Medical Santo in Vanuatu. He worked alongside clinicians from diverse specialties, supported daily clinic operations, and assisted in a diabetes research project. Outside the clinic, weekends on Tutuba Island profoundly impacted him. ‘Snorkelling and fishing with the children revealed a selfsufficient community whose joy came from simplicity and connection,’ he reflected. The experience honed his ability to deliver patient care with limited resources and introduced him to role models who reshaped his professional outlook. ‘It strengthened my commitment to equitable healthcare,’ Ken said. 陳衍樺選擇在增潤學年前往瓦努阿圖的Medical Santo組織擔任志 願者，與來自不同專科的臨床醫生並肩工作，協助診所日常營運， 並參與了一個糖尿病研究項目。工作之餘，他在Tutuba Island度 過的周末給他留下了深刻印象。「與孩子們一起浮潛和釣魚，讓我 看到他們自給自足、快樂的生活方式，簡單卻充實。」他回憶道。 這段經歷讓他學會如何在資源有限的情況下為病患提供最佳的照 顧，並讓他接觸到塑造他醫療願景的專業人士。「這經歷鞏固了我 對公平醫療的信念。」 Interdisciplinary Learning: From Biomedical Sciences to Medicine 跨學科學習：從生物醫學到醫學 Dr Ryan Lee 李宇軒醫生 Ken Tan Yan-hua 陳衍樺 15 HKUMed News Summer 2025
From Radiation Therapy to Medicine: A Journey of Confidence and Purpose 從放射治療到醫學： 一段充滿信心與使命的旅程 Jane credits her first degree in Radiation Therapy from the University of Toronto for shaping her confidence, determination, and patient care skills. Admitted through HKUMed’s Second Chance Scheme for degree holders, Jane’s journey reflects the value of prior academic and professional experience in medical training. ‘I approached the MBBS programme with more determination and readiness to contribute,’ said Jane, highlighting how her first degree helped her re-evaluate her interests and solidify her passion for medicine. Her clinical exposure during her radiation therapy internship in Canada was invaluable, making her more confident during ward visits and patient interactions. Her first degree also gave her an edge in anatomy classes, allowing her to grasp concepts more quickly. She has even applied her radiotherapy knowledge to design teaching tools for anatomy education, showcasing the interdisciplinary benefits of her background. 黃靖將其在加拿大多倫多大學攻讀的放射治療學士學位，視為塑造 她信心、決心和掌握患者護理技能的重要基石。通過醫學院的「毅 行醫路計劃」（為已持有學位的申請者而設）入學，黃靖的旅程展現 了學術與專業經驗在醫學領域中的價值。「我以更大的決心和準備投 入到MBBS課程中，並希望貢獻自己的力量。」黃靖表示，她的第 一個學位幫助她重新審視自己的興趣，並堅定了對醫學的熱愛。她 在加拿大放射治療實習期間的臨床經驗尤為寶貴，使她在臨床學習 和與患者互動時更有自信。她的第一個學位還使她在解剖學課程中 佔據優勢，能夠更快地掌握相關概念。她甚至運用自己的放射治療 知識，設計了解剖學的教學工具，充分體現了她跨學科背景的優勢。 Bridging Medicine and Research 醫學培訓與研究結合 Dr Matthew Hsu Shi-shin demonstrates the value of blending medical training with research to build a career as a clinician-scientist. During his Enrichment Year, he pursued the Master of Research in Medicine (MRes[Med]), a decision that significantly shaped his professional path. ‘I have always been drawn to advancements in medical science,’ said Dr Hsu. The MRes[Med] enabled him to engage in research, leading to his first publication in Hypertension. The research team’s study on the gut microbiome’s role in hypertension gained recognition from the American Heart Association. Attending conferences and interacting with global experts further enriched his perspective. ‘The MRes[Med] expanded my opportunities and strengthened my career prospects,’ Dr Hsu stated. His journey underscores the impact of combining clinical and research training. 徐士心醫生的經歷展示了如何結合醫學培訓與研究，讓他踏上成爲 臨床科學家的路途。在增潤學年期間，他選擇攻讀醫學研究碩士 （MRes[Med]），這對他的事業發展影響深遠。徐醫生說：「我一直 對醫學科研的創新與發展感興趣。」MRes[Med] 讓他能夠深入參與 研究，並於國際期刊《Hypertension》發表他第一份學術論文。團隊 研究了腸道微生物態與高血壓之間的聯繫，更獲得美國心臟協會頒 發國際獎項。徐醫生亦有機會參加學術會議，接觸國際知名專家。 這些都是令他大開眼界和振奮的經歷。徐醫生補充：「MRes[Med] 為我的事業生涯開闢了機會，同時提升了我的競爭力。」 FEATURE Jane Wong 黃靖 Dr Matthew Hsu Shi-shin 徐士心醫生 16
HKUMed held an appreciation dinner on 13 March 2025 to express its gratitude to the donors of its Endowed Professorships. The event was officiated by Professor Xiang Zhang, President and Vice-Chancellor of the University, Professor Gong Peng, Vice-President & Pro-Vice-Chancellor (Academic Development), and Professor Chak-sing Lau, Vice-President & Pro-Vice-Chancellor (Health) and Dean of Medicine. The attending donors and HKUMed staff enjoyed a warm and cordial atmosphere during the evening. The University of Hong Kong established the Endowed Professorships Scheme in 2005. Since its inception, the Scheme has become one of the most significant awards bestowed upon eminent academics within the University in support of their academic and research activities. Over 120 Endowed Professorships have been established at HKU, with more than half of them at HKUMed. Additionally, the University has established the Outstanding Young Professorships, which are designated for outstanding assistant professors or associate professors, further reinforcing HKU’s dedication to fostering the next generation of academic leaders. 醫學院於2025年3月13日舉行明德教授席感謝宴，邀請醫學院「明德教授席」的捐贈者參加， 並由港大校長張翔教授、副校長（學術發展）宮鵬教授及副校長（健康）兼醫學院院長劉澤星教授 主禮，親向捐贈者表達由衷的謝意。出席的捐贈者與醫學院教職員相談甚歡，氣氛熱鬧融洽。 香港大學自2005年起設立「明德教授席」，在捐贈者選定的學術範疇成立冠名的永久教授席， 支持冠名教授的教研工作。「明德教授席」設立以來，已成為大學授予校内學者的崇高榮譽， 至今共設有逾120席，其中醫學院更獲得超過一半席位。港大更設有「傑出青年教授席」，授予 助理教授或副教授，展示大學對培育出類拔萃的青年學者的承諾和決心。 An Evening of Gratitude: Endowed Professorship 明德教授席感謝宴 For the list of Endowed Professorships 明德教授席名單 17 HKUMed News Summer 2025
HKUMed is actively seeking outstanding scholars through its ‘140 for 140 Global Recruitment Campaign’ to address rapid advancements in teaching and research and to expand collaboration with Mainland China and globally. Building on a series of global events over the past two years, Professor Chak-sing Lau, Vice-President & Pro-Vice-Chancellor (Health) and Dean of Medicine, led another delegation to London in May 2025 to attract top talent, particularly in fields like medical research, artificial intelligence and big data. They also visited prestigious institutions, including the University of Oxford, the University of Cambridge, King's College London, the University College London, the University of Bristol and the Francis Crick Institute. Their efforts led to encouraging exchanges and potential partnerships. They also held a gathering with alumni and exchange students, further strengthening connections. The delegation included Professor Ivan Hung Fan-ngai, Associate Dean (Partnership & Engagement); Professor Michael Häusser, Director of the School of Biomedical Sciences and Chair Professor of Neuroscience; and Professor Khuloud T Al-Jamal, Head of the Department of Pharmacology and Pharmacy. 醫學院透過「140 for 140全球人才招聘計劃」，積極廣納優秀學者，以應對教學和科研的迅速發展，並拓展與內地及國際的合作。繼過去 兩年舉辦的連串全球活動，副校長（健康）兼醫學院院長劉澤星教授於今年5月再率團前往倫敦舉辦招聘活動，吸納人才，尤其是在醫學研究、 人工智能與大數據等範疇。代表團還到訪多所頂尖學府，包括牛津大學、劍橋大學、倫敦國王學院、倫敦大學學院、布里斯托大學和 Francis Crick Institute 等，並促成了後續交流和潛在的合作。他們還舉行聚會，聯繫當地校友和交流學生。代表團成員包括副院長（夥伴 拓展及協作）孔繁毅教授、生物醫學學院院長及講座教授Michael Häusser教授及藥理及藥劑學系系主任Khuloud T Al-Jamal教授。 In mid-2025, HKUMed showcased its leadership in healthcare innovation and global collaboration, spearheading initiatives in AI and biotechnology. On 26 May, Dean Professor Chak-sing Lau led a pivotal session titled ‘Unlocking the Potential of AI in Healthcare’ at the Asia Summit on Global Health. Co-organised by the HKSAR Government and the Hong Kong Trade Development Council, the session convened experts in computer science, medical data science and AI, along with representatives from the government and healthcare sectors. The discussion explored AI's transformative impact across medical research, education and healthcare services. Further highlighting HKUMed's expertise, on the following day, Professor Stephanie Ma Kwai-yee, University Associate Vice-President (Research and Innovation) (also with Biomedical Sciences), and Professor Brian Chung Hon-yin (Paediatrics and Adolescent Medicine, SClinMed) addressed cancer evolution and the urgent need for rare diseases treatments. Building on this momentum, HKUMed reinforced Hong Kong's status as a burgeoning biotech hub at BIO 2025 in Boston from 16 to 19 June. HKUMed representatives, including Professor Stephanie Ma Kwai-yee and Professor Joshua Ho Wing-kei, Assistant Dean (Innovation & Technology Transfer), joined a delegation of 16 leading life and health technology companies for the first time, led by Hong Kong Science and Technology Parks Corporation and InvestHK. Significantly, five of the participating companies are affiliated with HKUMed. The Faculty also showcased projects from its Centre for Translational Stem Cell Biology and Centre for Virology, Vaccinology and Therapeutics. This strategic presence amplified HKUMed's innovations on the world stage, attracting enterprise partnerships, talent and investment essential for solidifying Hong Kong's position as a leading global biotech centre. 港大醫學院於2025年中積極參與多項重要活動，彰顯其在醫療創新的領導地位。5月26日，院長劉澤星教授於香港特區政府及香港貿易 發展局合辦的「亞洲醫療健康高峰論壇」上，主持關鍵會議「發掘AI在醫療領域的潛能」，與各方專家深入探討AI如何革新醫學研究、教育 及醫療服務。大學協理副校長（研究及創新）馬桂宜教授（生物醫學學院）及鍾侃言教授（臨床醫學學院兒童及青少年科學系）翌日亦就癌症 演變、罕見疾病治療等發表見解。學院代表包括馬桂宜教授及助理院長（創新及技術轉移）何永基教授，於6月16至19日聯同香港科技園 公司及投資推廣署率領的16家頂尖生命健康科技企業代表團，首赴波士頓參與全球最大型生物科技博覽BIO 2025。參展企業中，五家與 醫學院密切相關。幹細胞轉化研究中心及病毒與疫苗研究中心的多項創新項目同步亮相，充分展示學院科研實力，成功吸引企業、人才及 投資者關注，有助提升香港作為國際領先生物科技中心的地位。 Global Outreach to Recruit Talent, Engage Alumni and Promote Collaboration 全球廣納賢才 滙聚校友 促進合作新機遇 HKUMed Drives Global Health Innovation: AI and Biotech 醫學院推動全球醫療健康：AI及生物科技 18
The Hong Kong Jockey Club Global Health Institute (HKJCGHI), a collaborative effort between the University of Hong Kong, the International Vaccine Institute, and the University of Cambridge, held its inaugural symposium on ‘Advancing Global Health Through Scientific Innovation’ earlier this year. Over 110 academic and industry experts gathered to discuss pressing health challenges and pandemic preparedness, with esteemed speakers sharing their insights on 100-Day Mission of the Coalition for Epidemic Preparedness Innovations (CEPI), breakthroughs in vaccine development―including AI-driven innovations, pneumococcal vaccines, and real-world effectiveness data. The symposium underscored HKJCGHI’s commitment to fostering collaboration and driving progress in global health. The event also marked HKJCGHI’s first Scientific Advisory Board (SAB) meeting, chaired by Dr Jakob Cramer, Director of Clinical Development, CEPI, to guide the Institute’s future direction. 由香港大學、國際疫苗研究所和劍橋大學合作成立的香港賽馬會環球 衞生研究院（HKJCGHI）今年初舉辦首屆「創新科學：推動全球健康」 研討會。活動匯聚逾110位學術界及業界專家，共同探討迫切的健康 挑戰與防疫準備，講者在會中分享多項關鍵議題，包括流行病防範創 新聯盟（CEPI）的「百日任務」、疫苗研發突破（如AI技術應用和肺炎球 菌疫苗演進）以及真實世界疫苗效用數據等。研討會彰顯了HKJCGHI 致力促進合作與推動全球健康發展的承諾。活動期間，研究院亦召開 科學諮詢委員會（SAB）首次會議，由CEPI臨床開發總監Jakob Cramer醫生擔任主席，為研究院未來的發展方向提供指導。 Symposium Advances Global Health Through Scientific Innovation 研討會推動科學創新 促進全球健康發展 For symposium details 研討會詳情 HKUMed, in partnership with the China Medical Board, the Hong Kong Academy of Medicine and Queen Mary Hospital, hosted the symposium ‘Grand Challenges in Medical Education – Training Doctors for the Fifth Industrial Revolution’ in November 2024. Professor Chak-sing Lau, Vice-President & Pro-Vice-Chancellor (Health) and Dean of Medicine, extended heartfelt gratitude to the distinguished national delegates from the Ministry of Education and the National Health Commission for their presence and for leading the delegation from the China Consortium of Elite Teaching Hospitals to engage with HKUMed’s faculty and students. The symposium convened a diverse assembly of stakeholders – including government officials, Consortium members, scholars in medical education and health management, students, and other professionals – to discuss the opportunities and challenges that the Fifth Industrial Revolution brings to medical education. 醫學院聯同美國中華醫學基金會、香港醫學專科學院及瑪麗醫院於2024年11月成功舉辦「第五次工業革命與 醫學教育變革研討會」。副校長（健康）兼醫學院院長劉澤星教授感謝國家教育部和國家衞生健康委員會的領導 親臨港大醫學院，並率領「中國精英教學醫院聯盟」代表團與醫學院師生交流。研討會匯聚了包括政府官員、 聯盟成員、醫學教育及衞生管理學者、學生及其他相關專業人士在內的不同持份者，共同探討第五次工業革 命為醫學教育帶來的新機遇和新挑戰。 ‘Grand Challenges in Medical Education – Training Doctors for the Fifth Industrial Revolution’ Symposium 第五次工業革命與醫學教育變革研討會 For symposium details 研討會詳情 19 HKUMed News Summer 2025
Over 600 graduates celebrated their academic achievements and a significant milestone in their lives with their fellow classmates, teachers, families and friends at the 213th Faculty Congregation held on 1 December 2024 in the Grand Hall of the HKU Centennial Campus. Professor Xiang Zhang, President and Vice-Chancellor of the University, the presiding officer of the Ceremony, conferred the degrees upon the graduands. Gracing the event as the Guest of Honour was Ambassador George Hara, Group Chairman and CEO, DEFTA Partners and Chairman of Board, Alliance Forum Foundation, who delivered an address on the occasion. Professor Chak-sing Lau, Vice-President & Pro-Vice-Chancellor (Health) and Dean of Medicine, delivered The Dean’s Letter, in which he outlined the translational initiatives of HKUMed for leveraging its research strengths and new developments in teaching and learning as well as recent collaborations with the Mainland and international partners. 逾600位畢業生在2024年12月1日於港大百周年校園大會堂舉行的 第213屆學位頒授典禮上，與同學、老師及親友同慶學有所成及分 享踏上人生新階段的喜悅。 典禮由港大校長張翔教授主持，並向畢業生頒授學位。DEFTA Partners集團主席兼行政總裁及Alliance Forum Foundation 董事 會主席原丈人大使應邀擔任特別嘉賓並致辭。 副校長（健康）兼醫學院院長劉澤星教授發表《院長親函》，概述醫學 院推動科研成果轉化的最新計劃、學院在教學方面的最新發展，以 及與內地及國際夥伴的最新合作。 Read The Dean’s Letter 閱讀《院長親函》 (只供英文版) The 213th Congregation 第213屆學位頒授典禮 ‘The next period in HKUMed’s development will undoubtedly be a busy one. We aim to achieve excellence through advancing our research strengths and opportunities, strengthening our partnerships, and enhancing our education programmes to ensure we produce capable and compassionate graduates.’ 「醫學院的下一個發展階段無疑將充滿 挑戰。我們將致力於提升研究實力和 機會、加強合作夥伴關係，以及優化 教育課程，確保學院培養出優秀且富有 仁心的畢業生。」 ―― Professor Chak-sing Lau 劉澤星教授 20
Professor Xiang Zhang, President and Vice-Chancellor of the University, confers a degree upon a graduand. 校長張翔教授為畢業生頒授學位。 ‘As you move forward in your medical career, I hope you will act not only to protect the health of the individual patients, but also to promote the health of society.’ 「希望你們在未來的職業生涯中不僅要守護病患的健康， 亦要促進社會的整體健康。」 ―― Ambassador George Hara 原丈人大使 21 HKUMed News Summer 2025
The first anti-cancer drug wholly invented and manufactured in Hong Kong has cleared hurdles for its wider clinical testing and future use around the world. HKUMed Cure for Leukaemia Advances Globally FEATURE+ 22
Oral-ATO as the new standard of care in APL The drug oral-ATO – which stands for oral formulation of arsenic trioxide – has already been shown in local and regional trials to be an effective cure for acute promyelocytic leukaemia (APL). Recently, it obtained orphan drug designation from the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), which recognise that the drug is a promising treatment for this rare disease. ‘Oral-ATO is a game-changer for APL patients because it is life-saving, cost-effective and preserves patients’ quality-of-life, and we take great pride in seeing our research translated into practice in Hong Kong and elsewhere. Our aim is to make APL a curable disease for patients around the world,’ said Professor Harinder Gill, Clinical Associate Professor in the Department of Medicine, SClinMed, who is now the lead investigator on the drug. A Long Road from Lab Bench to Patient Care But the journey to this stage has been long and involved multiple generations of scholars carrying the research forward. It all started back in 1997 when Professor Kwong Yok-lam, Chair of Haematology/ Oncology and Bone Marrow Transplantation, sought to make something old – and highly toxic – new again. The ‘something’ was arsenic, a substance often associated with murder in history. Arsenic trioxide was used in medicine for centuries but fell out of favour over its toxicity. However, in 1997 Professor Kwong read an article about the successful use of intravenous arsenic trioxide in treating leukaemia patients in Shanghai. He brought the article to his supervisor Professor David Todd, who recalled the successful use of oral arsenic trioxide in the early 1950s in Hong Kong. Professor Kwong confirmed the case. However, it was difficult to import medicine from the mainland at the time, and inspired by the 1950s case, he decided to develop an oral rather than intravenous formulation of arsenic trioxide. He teamed up with Professor Cyrus Kumana (now Emeritus), who was then chief in the Division of Clinical Pharmacology, to work on creating the oral formulation. Over the next three years, the team overcame challenges such as sourcing pharmaceutical grade arsenic trioxide powder, controlling its solubility and securing ethics approval, until they had a preparation that they felt could be safe and effective for patients. An unusual clinical trial was then organised. ‘We had no recourse to prior testing in normal volunteers because they would be unlikely to take arsenic. And there was no recourse to comparison with a placebo or dummy treatment. Instead, we treated patients with relapsed APL who were very, very sick,’ said Professor Kumana. Outstanding Clinical Results The results, which were followed up in a 15-year prospective study, found that among more than 80 relapsed patients treated with oral-ATO, there was a molecular remission rate of 100% and a five-year overall survival rate of 80%. Importantly, they were also able to show that oral-ATO had a bioavailability comparable with intravenous ATO. The team then tested oral-ATO as a maintenance treatment of APL patients in complete remission. Here ‘We had no recourse to prior testing in normal volunteers because they would be unlikely to take arsenic.’ Emeritus Professor Cyrus Kumana 23 HKUMed News Summer 2025
RkJQdWJsaXNoZXIy Mzg4NDg0